Business Context and Reporting Period
Company: Carlsmed, Inc. (CARL)
Filing Type: Form 8-K (Current Report)
Report Date: May 5, 2026
Reporting Period: Quarter ended March 31, 2026
Business Context: The filing serves as a notification that the Company issued a press release announcing its financial results for the quarter ended March 31, 2026. The full text of the press release is included as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended March 31, 2026.
Guidance, Outlook, and Risks
The filing text does not include specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It notes that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 5, 2026) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the full press release.
- Check for updated forward-looking guidance or clinical trial milestones mentioned in the press release.
- Confirm the status of the Company's emerging growth company election and any related accounting standard transitions.